SUPPLEMENT

Q1 2021 — Income statement trends

Q1 2021PDF · 2 pages140 KB
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q119 	Q219 	Q319 	Q419 	Q120 	Q220 	Q320 	Q420 	Q121
Revenues:
Clearing and transaction fees 	952.6 	1,051.8 	1,040.7 	901.0 	1,278.8 	940.2 	835.4 	843.0 	1,007.0
Market data and information services 	130.1 	128.3 	129.8 	130.3 	131.5 	134.7 	139.4 	139.8 	144.2
Other Revenue 	96.9 	92.6 	106.8 	107.1 	111.8 	107.4 	105.9 	115.7 	102.1
Total revenues 	1,179.6 	1,272.7 	1,277.3 	1,138.4 	1,522.1 	1,182.3 	1,080.7 	1,098.5 	1,253.3
Expenses:
Compensation and benefits 	230.3 	227.3 	223.5 	217.6 	207.5 	217.0 	216.4 	215.6 	225.0
Technology 	47.1 	48.6 	52.7 	53.1 	47.7 	49.1 	48.1 	53.6 	48.2
Professional fees and outside services 	39.4 	41.7 	43.2 	49.8 	41.7 	51.2 	48.4 	50.0 	37.4
Amortization of purchased intangibles 	80.7 	76.1 	79.8 	78.1 	77.3 	76.6 	78.3 	79.0 	60.6
Depreciation and amortization 	32.9 	46.3 	41.4 	38.0 	35.3 	36.7 	39.7 	41.5 	37.6
Licensing and other fee agreements 	40.5 	44.8 	45.6 	41.3 	73.9 	55.4 	57.7 	57.9 	64.7
Other expense 	77.7 	89.3 	105.9 	87.5 	78.8 	58.8 	67.1 	85.9 	54.7
Operating expenses 	548.6 	574.1 	592.1 	565.4 	562.2 	544.8 	555.7 	583.5 	528.2
Operating Income 	631.0 	698.6 	685.2 	573.0 	959.9 	637.5 	525.0 	515.0 	725.1
Operating Margin 	53% 	55% 	54% 	50% 	63% 	54% 	49% 	47% 	58%
Non-operating Income and Expense
Investment income 	178.7 	139.3 	172.3 	147.6 	95.9 	32.1 	23.6 	31.1 	30.9
Interest and other borrowing costs 	(48.1) 	(45.1) 	(42.8) 	(42.0) 	(40.9) 	(41.9) 	(41.7) 	(41.7) 	(41.5)
Equity in net gains of unconsolidated subsidiaries 	40.5 	43.8 	48.0 	44.5 	51.2 	48.8 	44.0 	46.6 	56.2
Other non-operating income (expense) 	(161.9) 	(134.5) 	(139.5) 	(99.0) 	(76.8) 	(15.2) 	(14.4) 	(16.0) 	(18.4)
Non-operating income (expense) 	9.2 	3.5 	38.0 	51.1 	29.4 	23.8 	11.5 	20.0 	27.2
Income before income taxes 	640.2 	702.1 	723.2 	624.1 	989.3 	661.3 	536.5 	535.0 	752.3
Income taxes 	144.3 	187.5 	86.9 	155.1 	222.5 	158.0 	125.0 	110.2 	177.5
Net income 	495.9 	514.6 	636.3 	469.0 	766.8 	503.3 	411.5 	424.8 	574.8
Less: net income (loss) attributable to NCI 	(1.0) 	0.8 	- 	(0.5) 	0.6 	- 	(0.2) 	0.8 	0.4
Net Income Attributable to CME Group 	496.9 	513.8 	636.3 	469.5 	766.2 	503.3 	411.7 	424.0 	574.4
Effective Tax Rate 	22.5% 	26.7% 	12.0% 	24.9% 	22.5% 	23.9% 	23.3% 	20.6% 	23.6%
Earnings per Share:
Basic EPS 	1.39 	1.44 	1.78 	1.31 	2.14 	1.41 	1.15 	1.18 	1.60
Diluted EPS 	1.39 	1.43 	1.78 	1.31 	2.14 	1.40 	1.15 	1.18 	1.60
Weighted average number of common stock shares:
Basic Shares 	356,886 	357,060 	357,211 	357,456 	357,524 	357,691 	357,791 	358,047 	358,147
Diluted Shares 	358,047 	358,155 	358,369 	358,354 	358,455 	358,457 	358,590 	358,612 	358,817

-- 1 of 2 --

CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF NON-GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q119 	Q219 	Q319 	Q419 	Q120 	Q220 	Q320 	Q420 	Q121
Revenues:
Clearing and transaction fees 	952.6 	1,051.8 	1,040.7 	901.0 	1,278.8 	940.2 	835.4 	843.0 	1,007.0
Market data and information services 	130.1 	128.3 	129.8 	130.3 	131.5 	134.7 	139.4 	139.8 	144.2
Other Revenue 	96.9 	92.6 	106.8 	107.1 	111.8 	107.4 	105.9 	115.7 	102.1
Total revenues 	1,179.6 	1,272.7 	1,277.3 	1,138.4 	1,522.1 	1,182.3 	1,080.7 	1,098.5 	1,253.3
Expenses:
Compensation and benefits 	219.7 	218.7 	219.2 	207.1 	210.9 	202.7 	205.5 	202.6 	207.5
Technology 	47.1 	48.1 	52.5 	51.5 	47.3 	48.5 	47.3 	52.2 	47.7
Professional fees and outside services 	33.7 	36.0 	37.1 	41.4 	35.3 	42.7 	40.0 	39.2 	27.9
Amortization of purchased intangibles 	- 	- 	- 	- 	- 	- 	- 	- 	-
Depreciation and amortization 	32.9 	35.7 	34.3 	35.1 	34.5 	33.7 	37.0 	37.2 	36.8
Licensing and other fee agreements 	40.5 	44.8 	45.6 	41.3 	73.9 	55.4 	57.7 	57.9 	64.7
Other expense 	69.4 	67.5 	66.4 	83.8 	57.6 	51.9 	56.1 	74.3 	52.1
Operating expenses 	443.3 	450.8 	455.1 	460.2 	459.5 	434.9 	443.6 	463.4 	436.7
Operating Income 	736.3 	821.9 	822.2 	678.2 	1,062.6 	747.4 	637.1 	635.1 	816.6
Operating Margin 	62% 	65% 	64% 	60% 	70% 	63% 	59% 	58% 	65%
Non-operating Income and Expense
Investment income 	176.7 	161.0 	165.4 	126.1 	102.3 	26.4 	22.6 	24.1 	26.9
Interest and other borrowing costs 	(48.1) 	(45.1) 	(42.8) 	(42.0) 	(42.6) 	(41.9) 	(41.7) 	(41.7) 	(41.5)
Equity in net gains of unconsolidated subsidiaries 	40.5 	43.8 	48.0 	44.5 	51.2 	48.8 	44.0 	46.6 	56.2
Other non-operating income (expense) 	(147.5) 	(132.2) 	(138.3) 	(99.2) 	(78.3) 	(15.2) 	(14.4) 	(16.0) 	(18.4)
Non-operating income (expense) 	21.6 	27.5 	32.3 	29.4 	32.6 	18.1 	10.5 	13.0 	23.2
Income before income taxes 	757.9 	849.4 	854.5 	707.6 	1,095.2 	765.5 	647.6 	648.1 	839.8
Income taxes 	179.7 	217.0 	175.3 	163.7 	258.8 	182.3 	152.8 	150.2 	198.2
Net income 	578.2 	632.4 	679.2 	543.9 	836.4 	583.2 	494.8 	497.9 	641.6
Less: net income (loss) attributable to NCI 	(1.0) 	0.8 	- 	(0.5) 	0.6 	- 	(0.2) 	0.8 	0.4
Net Income Attributable to CME Group 	579.2 	631.6 	679.2 	544.4 	835.8 	583.2 	495.0 	497.1 	641.2
Effective Tax Rate 	23.7% 	25.6% 	20.5% 	23.1% 	23.6% 	23.8% 	23.6% 	23.2% 	23.6%
Earnings per Share:
Basic EPS 	1.62 	1.77 	1.90 	1.52 	2.34 	1.63 	1.38 	1.39 	1.79
Diluted EPS 	1.62 	1.76 	1.90 	1.52 	2.33 	1.63 	1.38 	1.39 	1.79
Weighted average number of common stock shares:
Basic Shares 	356,886 	357,060 	357,211 	357,456 	357,524 	357,691 	357,791 	358,047 	358,147
Diluted Shares 	358,047 	358,155 	358,369 	358,354 	358,455 	358,457 	358,590 	358,612 	358,817

-- 2 of 2 --